메뉴 건너뛰기




Volumn 4, Issue 3, 1997, Pages 279-285

Cartels, spontaneous price discrimination and international pharmacy retailing

Author keywords

Antitrust policy; Health care; Jel classifications: k21, l41, l65, i11; Pharmaceutical industry; Retail pharmacies

Indexed keywords


EID: 0001911280     PISSN: 13571516     EISSN: 14661829     Source Type: Journal    
DOI: 10.1080/758523210     Document Type: Article
Times cited : (6)

References (11)
  • 1
    • 84912407404 scopus 로고
    • 6th edn, Englewood Cliffs, NJ: Prentice-Hall
    • Bach, G.L., 1968. Economics, 6th edn, Englewood Cliffs, NJ: Prentice-Hall.
    • (1968) Economics
    • Bach, G.L.1
  • 4
    • 0000203315 scopus 로고
    • On the Measurement of the Utility of Public Works
    • Arrow K.J., Saitovsky T., (eds), London: Allen and Unwin,. Edited by
    • Dupuit, J., 1969. “On the Measurement of the Utility of Public Works”. In Readings in Welfare Economics, Edited by: Arrow, K.J., and Saitovsky, T., London: Allen and Unwin.
    • (1969) Readings in Welfare Economics
    • Dupuit, J.1
  • 6
    • 6844253629 scopus 로고    scopus 로고
    • Washington, DC
    • Pharmaceutical Research and Manufacturers Of America. 1997. Industry Profile Washington, DC
    • (1997) Industry Profile
  • 7
    • 85065358196 scopus 로고    scopus 로고
    • Institute of Economic Affairs
    • London:. In
    • Reekie, W.D., 1996. “ Institute of Economic Affairs ”. In Medicine Prices and Innovations, Choice in Welfare Series No.30 London
    • (1996) Medicine Prices and Innovations
    • Reekie, W.D.1
  • 8
    • 85065359922 scopus 로고
    • Common Costs in Pharmaceutical Research and Development. Implications forDirect Price Regulation
    • Mitchell S.A., Link E.A., (eds), American University Press,. Edited by
    • Schankerman, M.A. 1976. “Common Costs in Pharmaceutical Research and Development. Implications forDirect Price Regulation,”. In Impact of Public Policy on DrugInnovations and Pricing, Edited by: Mitchell, S.A, and Link, E.A. American University Press.
    • (1976) Impact of Public Policy on DrugInnovations and Pricing
    • Schankerman, M.A.1
  • 9
    • 84927093058 scopus 로고    scopus 로고
    • How US Antitrust Can Go Astray: The Brand Name Prescription Drug Litigation
    • Scherer, F.M., 1997. “How US Antitrust Can Go Astray: The Brand Name Prescription Drug Litigation"”. International Journal of Business and Economics, 4 (3): 239–256.
    • (1997) International Journal of Business and Economics , vol.4 , Issue.3 , pp. 239-256
    • Scherer, F.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.